MedTrace Logo

Asphyxia Associated Metabolite Biomarker Investigation (AAMBI)

NCT03354208 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 155

Last updated 2021-01-12

No results posted yet for this study

Summary

Verification of biomarkers in a human population for their ability to diagnose the severity of neonatal asphyxia. These biomarkers linked to asphyxia have been identified in animal studies.

Conditions

  • Asphyxia Neonatorum

Interventions

OTHER

blood sampling

small volume blood sampling, according to local laws, is not categorized as intervention (observational study)

Sponsors & Collaborators

  • Cukurova University

    collaborator OTHER

  • University Children's Hospital Tuebingen

    collaborator OTHER

  • Life Science Inkubator

    lead OTHER

Principal Investigators

  • Ron Meyer · Life Science Inkubator Betriebs GmbH & Co. KG

Eligibility

Min Age
0 Hours
Max Age
2 Hours
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2017-12-27
Completion
2017-12-27

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03354208 on ClinicalTrials.gov